Johnson & Johnson’s $8 Billion Risperdal Judgment Reduced to $6.8 Million
“The judge presiding over a case which saw Johnson & Johnson hit with an $8bn jury verdict has reduced the amount the company has to pay in damages to $6.8m.” reports PM Live.
“Last October, J&J was ordered to pay $8bn in damages to a US man who claims he was not warned that taking the company’s antipsychotic Risperdal could lead to breast growth.” A jury in Philidelphia agreed with his allegations.
Johnson & Johnson appealed the verdict arguing the size of the payout was “grossly disproportionate”.
Read PM Live‘s article.
